J. N. van den Anker

发表

Possible effects of repeated exposure to ibuprofen and acetaminophen on the intestinal immune response in young infants.

K. Allegaert, F. Smets, F. Veyckemans, 2016, Medical hypotheses.

Neonatal drug therapy: The first frontier of therapeutics for children

K. Allegaert, J. Anker, J. N. van den Anker, 2015, Clinical pharmacology and therapeutics.

P104 Pharmacologic differences of adalimumab, infliximab and etanercept: do we need specific vaccination recommendations for prenatally exposed infants?

V. Gotta, T. Welzel, N. Rakhmanina, 2019, Archives of Disease in Childhood.

O39 Defining serum CCL22 and trefoil factor 3 (TFF3) as pharmacodynamic biomarkers for use in a proof-of-concept clinical trial of vamorolone in paediatric ulcerative colitis

Y. Hathout, A. Panigrahi, H. Gordish-Dressman, 2019, Archives of Disease in Childhood.

Covariates of tramadol disposition in the first months of life.

D. Tibboel, R. V. van Schaik, G. Naulaers, 2008, British journal of anaesthesia.

Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity.

D. Tibboel, K. Allegaert, B. Anderson, 2005, British journal of anaesthesia.

Pharmacokinetics and renal function in preterm infants

J. N. van den Anker, J. N. Van den Anker, 1996, Acta paediatrica.

Postmenstrual age and CYP2D6 polymorphisms determine urinary tramadol O-demethylation excretion in critically ill neonates and infants

R. V. van Schaik, K. Allegaert, J. D. de Hoon, 2008, Critical Care.

Contribution of glucuronidation to tramadol disposition in early neonatal life.

D. Tibboel, G. Naulaers, K. Allegaert, 2006, Basic & clinical pharmacology & toxicology.

Determinants of variability in clearance of exogenous compounds in neonates.

K. Allegaert, C. Tayman, J. D. de Hoon, 2009, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie.